title: Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
authors: Neurology Unit, Università Campus Bio-Medico, Rome, Italy; Neurology Unit, Treviglio Hospital, Treviglio, Bergamo, Italy. Electronic address: jmmelgari@tiscali.it.
authors: Jean-Marc
authors: JM
authors: Melgari
authors: Neurology Unit, Università Campus Bio-Medico, Rome, Italy.
authors: Massimo
authors: M
authors: Marano
authors: Radiology Unit, Università Campus Bio-Medico, Rome, Italy.
authors: Carlo Cosimo
authors: CC
authors: Quattrocchi
authors: Human Molecular Genetics Consortium, Monza, Italy; University of Milano-Bicocca, Department of Health Sciences, Monza, Italy.
authors: Alberto
authors: A
authors: Piperno
authors: Human Molecular Genetics Consortium, Monza, Italy.
authors: Cristina
authors: C
authors: Arosio
authors: CNR Institute of Translational Pharmacology, Rome, Italy; Medical Genetics Unit, Policlinico Tor Vergata, Rome, Italy.
authors: Marina
authors: M
authors: Frontali
authors: Medical Genetics Unit, Policlinico Tor Vergata, Rome, Italy.
authors: Sara
authors: S
authors: Nuovo
authors: Don Carlo Gnocchi Foundation ONLUS, Milan, Italy.
authors: Mariacristina
authors: M
authors: Siotto
authors: Neurology Unit, Università Campus Bio-Medico, Rome, Italy.
authors: Gaetano
authors: G
authors: Salomone
authors: Neurology Unit, Università Campus Bio-Medico, Rome, Italy.
authors: Riccardo
authors: R
authors: Altavilla
authors: Neurology Unit, Università Campus Bio-Medico, Rome, Italy.
authors: Lazzaro
authors: L
authors: di Biase
authors: Neurology Unit, Treviglio Hospital, Treviglio, Bergamo, Italy.
authors: Federica
authors: F
authors: Scrascia
authors: Fatebenefratelli Foundation, AFaR Division, Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy.
authors: Rosanna
authors: R
authors: Squitti
authors: Neurology Unit, Università Campus Bio-Medico, Rome, Italy.
authors: Fabrizio
authors: F
authors: Vernieri
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D001921:Brain / Q000473:pathology*; D002570:Ceruloplasmin / Q000172:deficiency* / Q000235:genetics; D002819:Chorea / Q000209:etiology; D003937:Diagnosis, Differential; D004421:Dystonia / Q000209:etiology; D005260:Female; D006801:Humans; D019189:Iron Metabolism Disorders / Q000235:genetics*; D019190:Iron Overload / Q000150:complications* / Q000235:genetics; D008875:Middle Aged; D009069:Movement Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D019636:Neurodegenerative Diseases / Q000235:genetics*; D013747:Tetrabenazine / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D002570:Ceruloplasmin; D013747:Tetrabenazine
keywords: Ceruloplasmin; Chorea; Dystonia; NBIA; Tetrabenazine